Mery-sur-Cher, France

Ab Medica

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 22.2


Trademarks = 4

Forward Citations = 29

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Alexandre Blanc (3 out of 3 patents)

silverMedal Ferdinando De Negri (1 out of 2 patents)

bronzeMedal Pietro Valdastri (1 out of 12 patents)

4.  Cosimo Damiano Puttilli (1 out of 1 patent)

5.  Mauro Picciafuoco (1 out of 1 patent)

6.  Pantaleo Romanelli (1 out of 2 patents)

7.  Antonino Paris (1 out of 3 patents)

8.  Stefano Marchetti (1 out of 3 patents)

9.  Dante David (1 out of 11 patents)

10.  Carlo Rebuffat (1 out of 13 patents)

11.  Paolo Cristiani (1 out of 1 patent)

12.  Panlaleo Romanelli (1 out of 1 patent)

13.  Fabio Sebastiano (1 out of 1 patent)

14.  Riccardo Rosati (1 out of 4 patents)

15.  Danilo Ferrari (1 out of 1 patent)


9 patents:

Company Overview
Ab Medica S.p.a. is a leading Italian company specializing in the development, production, and commercialization of medical devices and diagnostic systems. With over 50 years of experience in the healthcare industry, Ab Medica is dedicated to improving patient outcomes through innovative and high-quality products. Their portfolio includes cutting-edge solutions for hemodialysis, surgical interventions, and diagnostic testing, serving healthcare professionals worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

9 Patents

#1 in Mery-sur-Cher

#1,854 in France

Mery-sur-Cher, FR
Mery-sur-Cher, France
Forward Citations = 29

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ab Medica. Retrieved from https://idiyas.com/company/ab-medica

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…